Today at 1:00 PM EST
Click here for the link.
Here is a description:
The prosecution of global businesses under the Foreign Corrupt Practices Act (FCPA) is on the rise, with pharmaceutical and life sciences companies at the top of the DOJ’s list for investigations. Penalties in the hundreds of millions are no longer unusual. Under the FCPA companies can be liable for violations by agents, intermediaries and subsidiaries, as well as employees.
In this webinar, experienced enforcement and compliance attorney William Barry, of Richards Kibbe & Orbe LLP, will discuss how pharmaceutical companies can protect themselves and their employees from prosecution for FCPA violations. This presentation is tailored for compliance and legal professionals in the pharmaceutical industry, as well as marketing and operational personnel involved in cross-border business in the industry. Topics covered will include:
- FCPA Prohibited Payments
- Record Keeping and Accounting Controls Provision
- Internal Compliance Programs
- High Risk Areas in the Pharmaceutical Industry and FCPA Risk Mitigation Essentials